HistoSonics, Inc.

HistoSonics is a venture-backed medical device company whose mission is to redefine cancer treatment with a non-invasive, highly precise, cost-effective method of tumor destruction called Robotically Assisted Sonic Therapy (RAST)(tm). This new modality in development – which is non-thermal and does not use radiation – has the potential to treat a broad range of cancers in an outpatient setting, without the incisions, punctures, nausea, pain, fatigue, scarring and long recovery times associated with existing methods of cancer treatment. RAST is based on the science of histotripsy, a non-invasive ablation modality developed at the University of Michigan that mechanically homogenizes target tissue, resulting in complete cellular destruction. Our Mission At HistoSonics, we come to work every day with one mission in mind: To help people win the fight against cancer. Our job is to create a world where cancer is treated without scalpels or needles and with as little patient suffering or recovery time as possible. We intend to beat cancer by leading the development of non-invasive, highly precise treatments at an affordable cost. Every day, we move closer to our goal.